Acadian Asset Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.97M Buy
240,264
+82,998
+53% +$681K ﹤0.01% 834
2025
Q1
$1.12M Buy
+157,266
New +$1.12M ﹤0.01% 910
2024
Q4
Sell
-133,817
Closed -$1.4M 2070
2024
Q3
$1.4M Buy
133,817
+91,525
+216% +$959K ﹤0.01% 845
2024
Q2
$494K Buy
+42,292
New +$494K ﹤0.01% 1200
2023
Q1
Sell
-21,873
Closed -$494K 1929
2022
Q4
$494K Buy
+21,873
New +$494K ﹤0.01% 1036
2022
Q3
Sell
-17,804
Closed -$440K 1815
2022
Q2
$440K Buy
+17,804
New +$440K ﹤0.01% 1013
2019
Q3
Sell
-9,778
Closed -$503K 1981
2019
Q2
$503K Sell
9,778
-98,845
-91% -$5.08M ﹤0.01% 1019
2019
Q1
$6.23M Buy
108,623
+88,300
+434% +$5.06M 0.03% 392
2018
Q4
$853K Sell
20,323
-26,084
-56% -$1.09M ﹤0.01% 779
2018
Q3
$3.5M Sell
46,407
-24,459
-35% -$1.85M 0.01% 443
2018
Q2
$5.08M Buy
+70,866
New +$5.08M 0.02% 383
2017
Q2
Sell
-14,107
Closed -$272K 1558
2017
Q1
$272K Buy
+14,107
New +$272K ﹤0.01% 996